Collaboration Brings “Excitement” to Novel Cancer Therapy Development
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, described the excitement of seeing novel molecules like antibody drug conjugates become more prominent.
Previous Post
Chemoimmunotherapy Less Safe, Efficacious in Younger ES-SCLC Population
Next Post
Pediatric Pharmacists Are Expanding Their Reach in Hospitals and Beyond: Marry Vuong, PharmD, BCPPS
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago